Valuation: Biogen Inc.

Market Cap 30.37B 26.58B 24.49B 22.7B 43.09B 2,882B 43.79B 294B 114B 1,422B 114B 112B 4,917B P/E 2026 *
31.3x
P/E 2027 * 17.2x
Enterprise Value 35.8B 31.33B 28.87B 26.76B 50.8B 3,398B 51.62B 346B 135B 1,677B 134B 131B 5,796B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 3.24x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day-1.32%
1 week-4.79%
Current month-4.79%
1 month+5.30%
3 months+17.13%
6 months+10.05%
Current year+16.88%
1 week 205.65
Extreme 205.65
219.02
1 month 193.2
Extreme 193.195
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
282.74
5 years 110.04
Extreme 110.035
372.12
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 13/11/2022
Director of Finance/CFO 60 28/02/2025
Chief Tech/Sci/R&D Officer - 31/12/2020
Director TitleAgeSince
Director/Board Member 69 22/03/2010
Director/Board Member 77 31/12/2009
Director/Board Member 72 18/06/2019
Date Insider Type Main position Quantity % Market Cap.
06-08Free

Chairman

2,005 0.0014%
06-08Fiscal year

Director

6,245 0.0042%
06-08Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.32%-4.79%+58.07%-25.22% 30.37B
+4.07%+8.45%+25.67%-2.34% 68.8B
-0.83%-2.40%+47.97%+220.88% 55.21B
+1.21%+42.20%+42.20%+42.20% 43.46B
+0.27%+8.33%-49.87%-53.43% 41.18B
-2.48%+13.91%+166.79%-32.89% 31.65B
+2.10%+4.14%+75.49%+90.19% 23.58B
-1.15%+8.29%+4.42%+184.96% 19.33B
-1.35%+2.34%+65.31%+132.45% 17.16B
+0.21%+4.61%+79.10%+361.28% 15.27B
Average +0.05%+4.32%+51.52%+91.81% 34.6B
Weighted average by Cap. +0.52%+4.21%+44.60%+67.49%

Financials

2026 *2027 *
Net sales 10.05B 8.8B 8.11B 7.51B 14.26B 954B 14.49B 97.19B 37.8B 471B 37.73B 36.92B 1,627B 10.39B 9.09B 8.38B 7.76B 14.74B 986B 14.97B 100B 39.06B 486B 38.99B 38.15B 1,681B
Net income 1.52B 1.33B 1.23B 1.14B 2.16B 144B 2.19B 14.72B 5.72B 71.3B 5.71B 5.59B 246B 1.97B 1.72B 1.59B 1.47B 2.79B 187B 2.84B 19.04B 7.4B 92.22B 7.39B 7.23B 319B
Net Debt 5.43B 4.75B 4.38B 4.06B 7.7B 515B 7.83B 52.51B 20.42B 254B 20.38B 19.94B 879B 3.31B 2.9B 2.67B 2.47B 4.7B 314B 4.77B 32.01B 12.45B 155B 12.43B 12.16B 536B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
07/07/26 US$205.70 -1.32% 1,156,880
06/07/26 US$208.46 -3.54% 1,218,492
02/07/26 US$216.12 +3.04% 1,155,165
01/07/26 US$209.74 -2.93% 1,138,639
30/06/26 US$216.06 -0.26% 1,091,325
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
205.70USD
Average target price
222.45USD
Spread / Average Target
+8.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock